Incoming ABPI president 'prepared to call out poor behavior'

The current boss of AstraZeneca (LSE: AZN) in the UK has taken over the role of president at the Association of the British Pharmaceutical Industry (ABPI), the leading trade body representing pharma companies in the UK.

Lisa Anson formally began the two-year position at the group’s annual conference, replacing John Kearney of Amgen (Nasdaq: AMGN).

Speaking at the event, she urged companies to “do much more to highlight the value of the industry to the future productivity of the National Health Service (NHS) and to ‘UK plc’.”